"Global Drug Eluting Balloon Market Overview:
Global Drug Eluting Balloon Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global Drug Eluting Balloon Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Drug Eluting Balloon involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Drug Eluting Balloon Market:
The Drug Eluting Balloon Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Drug Eluting Balloon Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Drug Eluting Balloon Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Drug Eluting Balloon market has been segmented into:
Coronary Drug Eluting Balloon
Peripheral Drug Eluting Balloon
Others
By Application, Drug Eluting Balloon market has been segmented into:
FreePac
TransPac
EnduraCoa
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Drug Eluting Balloon market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Drug Eluting Balloon market.
Top Key Players Covered in Drug Eluting Balloon market are:
Boston Scientific Corporation
BD
Terumo Corporation
Medtronic
B. Braun SE
Surmodicsinc.
Biotronik
Cook Medical
Opto Circuits (India) Limited
Lepu Medical Technology
Cardionovum GmbH
Shanghai MicroPort Medical (Group) Co. Ltd
Wellinq
Philips Healthcare
Biosensors International Group Ltd
"
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Drug Eluting Balloon Market by Type
4.1 Drug Eluting Balloon Market Snapshot and Growth Engine
4.2 Drug Eluting Balloon Market Overview
4.3 Coronary Drug Eluting Balloon
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Coronary Drug Eluting Balloon: Geographic Segmentation Analysis
4.4 Peripheral Drug Eluting Balloon
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Peripheral Drug Eluting Balloon: Geographic Segmentation Analysis
4.5 Others
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Others: Geographic Segmentation Analysis
Chapter 5: Drug Eluting Balloon Market by Application
5.1 Drug Eluting Balloon Market Snapshot and Growth Engine
5.2 Drug Eluting Balloon Market Overview
5.3 FreePac
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 FreePac: Geographic Segmentation Analysis
5.4 TransPac
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 TransPac: Geographic Segmentation Analysis
5.5 EnduraCoa
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 EnduraCoa: Geographic Segmentation Analysis
5.6 Others
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Drug Eluting Balloon Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 BOSTON SCIENTIFIC CORPORATION
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 BD
6.4 TERUMO CORPORATION
6.5 MEDTRONIC
6.6 B. BRAUN SE
6.7 SURMODICSINC.
6.8 BIOTRONIK
6.9 COOK MEDICAL
6.10 OPTO CIRCUITS (INDIA) LIMITED
6.11 LEPU MEDICAL TECHNOLOGY
6.12 CARDIONOVUM GMBH
6.13 SHANGHAI MICROPORT MEDICAL (GROUP) CO.
6.14 LTD.
6.15 WELLINQ
6.16 PHILIPS HEALTHCARE
6.17 BIOSENSORS INTERNATIONAL GROUP
6.18 LTD.
Chapter 7: Global Drug Eluting Balloon Market By Region
7.1 Overview
7.2. North America Drug Eluting Balloon Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Coronary Drug Eluting Balloon
7.2.4.2 Peripheral Drug Eluting Balloon
7.2.4.3 Others
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 FreePac
7.2.5.2 TransPac
7.2.5.3 EnduraCoa
7.2.5.4 Others
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Drug Eluting Balloon Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Coronary Drug Eluting Balloon
7.3.4.2 Peripheral Drug Eluting Balloon
7.3.4.3 Others
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 FreePac
7.3.5.2 TransPac
7.3.5.3 EnduraCoa
7.3.5.4 Others
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Drug Eluting Balloon Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Coronary Drug Eluting Balloon
7.4.4.2 Peripheral Drug Eluting Balloon
7.4.4.3 Others
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 FreePac
7.4.5.2 TransPac
7.4.5.3 EnduraCoa
7.4.5.4 Others
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Drug Eluting Balloon Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Coronary Drug Eluting Balloon
7.5.4.2 Peripheral Drug Eluting Balloon
7.5.4.3 Others
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 FreePac
7.5.5.2 TransPac
7.5.5.3 EnduraCoa
7.5.5.4 Others
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Drug Eluting Balloon Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Coronary Drug Eluting Balloon
7.6.4.2 Peripheral Drug Eluting Balloon
7.6.4.3 Others
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 FreePac
7.6.5.2 TransPac
7.6.5.3 EnduraCoa
7.6.5.4 Others
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Drug Eluting Balloon Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Coronary Drug Eluting Balloon
7.7.4.2 Peripheral Drug Eluting Balloon
7.7.4.3 Others
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 FreePac
7.7.5.2 TransPac
7.7.5.3 EnduraCoa
7.7.5.4 Others
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Drug Eluting Balloon Scope:
|
Report Data
|
Drug Eluting Balloon Market
|
|
Drug Eluting Balloon Market Size in 2025
|
USD XX million
|
|
Drug Eluting Balloon CAGR 2025 - 2032
|
XX%
|
|
Drug Eluting Balloon Base Year
|
2024
|
|
Drug Eluting Balloon Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Boston Scientific Corporation, BD, Terumo Corporation, Medtronic, B. Braun SE, Surmodicsinc., Biotronik, Cook Medical, Opto Circuits (India) Limited, Lepu Medical Technology, Cardionovum GmbH, Shanghai MicroPort Medical (Group) Co., Ltd., Wellinq, Philips Healthcare, Biosensors International Group, Ltd..
|
|
Key Segments
|
By Type
Coronary Drug Eluting Balloon
Peripheral Drug Eluting Balloon
Others
By Applications
FreePac
TransPac
EnduraCoa
Others
|
